Category: Molecular Biology
Global Molecular Biology
-
Global Exosomes Market - 2023-2030 (1)
... 200 nm, are secreted from cells to mediate signaling in the tumor necrosis factor (TNF)-induced mesenchymal stem cells (TME). Oncogenic EGFR can be shed from cells and interact with other TME cells. Exosomes from gastric ... Read More
-
Global Liquid Biopsy Market - 2024 - 2031
... to exhibit a CAGR of 15.4% during the forecast period 2024-2031. Liquid biopsy is a non-invasive medical test that detects and analyzes genetic and molecular alterations in a patient's blood or other bodily fluids. It ... Read More
-
Liquid Biopsy For Cancer Diagnostics Global Market Opportunities And Strategies To 2034 Including: 1) By Type: Product; Services 2) By Cancer: Lung Cancer; Breast Cancer; Colon Cancer 3)By Sample: Blood; Urine; Saliva 4) By End User: Hospitals; Diagnostic Centers Covering: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Guardant Health Inc.; Illumina Inc.; Exact Sciences Corporation
... biopsy for cancer diagnostics market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies. Understand how ... Read More
-
Single Cell Analysis Market Size, Share & Trends By Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2029
... growth of this market can be attributed to the increasing focus on personalized medicine. The rising R&D investments pharmaceutical & biotechnology industries is propelling the growth of single-cell analysis. Additionally, factors such as growth in ... Read More
-
Molecular Infectious Disease Testing Market by Product & Service (Kits, Instruments), Type (Singleplex, Multiplex), Test Type (Lab, PoC), Disease (STD, Flu, GI, HAI), Technology (PCR, NGS), End User (Diagnostic Labs, Hospitals) - Global Forecast to 2029
... advancements in molecular diagnostic technologies are the main driving force in the molecular infectious disease testing market. Advancements in PCR, next-generation sequencing, and other technologies enhance test accuracy, speed of completion, and efficiency, making them ... Read More
-
Global Latent TB Testing Market (2025 Edition): Analysis By Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User, By Region, By Country: Market Insights and Forecast (2020-2030)
... Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User (Diagnostic Laboratories, Hospitals and Clinics, and Academic and Research Institute), for the historical period of 2020-2023, the estimates of 2024 ... Read More
-
Gel Documentation Systems
... at a CAGR of 4.1% over the analysis period 2024-2030. Gel Documentation Instruments, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$173.1 Million by the end ... Read More
-
Competent Cells
... CAGR of 7.8% over the analysis period 2024-2030. Electrocompetent Cells, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$1.2 Billion by the end of the analysis ... Read More
-
Oligonucleotide Synthesis
... CAGR of 15.6% over the analysis period 2024-2030. Oligonucleotide-Based Drugs, one of the segments analyzed in the report, is expected to record a 17.3% CAGR and reach US$8.6 Billion by the end of the analysis ... Read More
-
Real-time PCR (qPCR) and Digital PCR (dPCR)
... expected to reach US$8.4 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Quantitative Technology, one of the segments analyzed in the report, is expected to record a 5.7% CAGR ... Read More
-
Molecular Breeding
... CAGR of 17.6% over the analysis period 2024-2030. Marker-Assisted Selection (MAS) Process, one of the segments analyzed in the report, is expected to record a 18.1% CAGR and reach US$11.7 Billion by the end of ... Read More
-
Transfection Technologies
... CAGR of 7.3% over the analysis period 2024-2030. Protein Production Application, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$694.1 Million by the end of the ... Read More
-
Transfection Reagents and Equipment
... 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Transfection Reagents, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.2 Billion by the ... Read More
-
Exosome Research Products
... at a CAGR of 20.6% over the analysis period 2024-2030. Exosome Research Kits & Reagents, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$697.8 Million by ... Read More
-
Polymerase Chain Reaction Consumables
... 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. PCR Tubes, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$250.5 Million by the ... Read More
-
qPCR and dPCR Instrumentation
... 2030, growing at a CAGR of 9.0% over the analysis period 2024-2030. qPCR Instrumentation, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$11.3 Billion by the ... Read More
-
In Situ Hybridization (ISH)
... 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Fluorescence In Situ Hybridization (FISH), one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$1.1 ... Read More
-
Liquid Biopsy
... CAGR of 17.9% over the analysis period 2024-2030. Liquid Biopsy Assay Kits, one of the segments analyzed in the report, is expected to record a 18.0% CAGR and reach US$12.8 Billion by the end of ... Read More
-
Pyrogen Testing
... CAGR of 10.4% over the analysis period 2024-2030. Pyrogen Testing Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$1.1 Billion by the ... Read More
-
Polymerase Chain Reaction
... at a CAGR of 5.0% over the analysis period 2024-2030. PCR Instruments, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.4 Billion by the end of ... Read More
-
Synthetic Biology
... CAGR of 27.9% over the analysis period 2024-2030. Oligonucleotides & Synthetic DNA Tool, one of the segments analyzed in the report, is expected to record a 29.1% CAGR and reach US$39.5 Billion by the end ... Read More
-
Molecular Cytogenetics
... CAGR of 8.8% over the analysis period 2024-2030. Molecular Cytogenetics Consumables, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$2.0 Billion by the end of the ... Read More
-
qPCR Reagents
... CAGR of 7.4% over the analysis period 2024-2030. Dye-Based qPCR Reagents, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$2.5 Billion by the end of the ... Read More
-
Exosomes
... 11.3% over the analysis period 2024-2030. Other Disease Indications, one of the segments analyzed in the report, is expected to record a 11.3% CAGR and reach US$377.0 Million by the end of the analysis period. ... Read More
-
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
... with a compound annual growth rate (CAGR) projection. The report includes an overview of the industry structure and its competitive landscape. Leading market players’ profiles, product offerings, financial information and recent market activities are provided. ... Read More
Research Assistance
